Tender detail

Supply of the 177Lu-PSMA radiopharmaceutical

Summary

Hradec Králové University Hospital is procuring recurring deliveries of the 177Lu-PSMA radiopharmaceutical, (177Lu) vipivotide tetraxetan, as an injection solution for intravenous use in the treatment of prostate cancer. The single lot covers deliveries to the hospital’s premises as needed over four years. The estimated contract value is CZK 59,345,304.

Reference number
784117-2026
Buyer
Fakultní nemocnice Hradec Králové
Country
Czechia (CZE)
Procedure
Open procedure
CPV
09343000 Radioactive materials
Deadline
2026-12-15
Status
Open
Contract subject
Supplies
Estimated value
59 345 304,00 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.